Orion S.A.
OEC NYSEΒ· Miscellaneous Chemical Products
Last close Β· Oct 26, 2026
$5.37
KIRA Β· Stoqlyβs AI analyst, in plain words
- Orion S.A. had $1.8B of revenue in fiscal 2025, down 3.8% on the year before. Over five years, revenue changed +9.7% a year on average.
- Its operating margin was 1.5%, down 3.9Β pts: of every 100 in sales, about 2 is left after running the business.
- Orion S.A. lost $70.1M in fiscal 2025.
- Free cash flow was $54.8M in fiscal 2025, 3.0% of revenue.
- Orion S.A. returned $29.5M to shareholders in fiscal 2025, 54% of free cash flow. The diluted share count fell 3.5%.
- Orion S.A. owes $1.3B more than it holds in cash, about 8.1 years of operating profit.
Market cap
$308M
P/E
β
Revenue
$1.8B
Net income
β$70.1M
Free cash flow
$54.8M
Operating margin
1.5%
Orion S.A. in 30 seconds Β· fiscal 2025
Are sales growing?
β3.8%
No. Sales fell 3.8% last year.
Does it make a profit?
β3.9%
No. It lost money last year.
Does profit turn into cash?
3.0%
Partly. 3.0% of sales ends up as free cash.
Is debt under control?
8.1x
Heavy. Repaying its debt would take 8.1 years of operating profit.
How healthy are the accounts?
3 / 9
Weak. It passes 3 of 9 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
What Orion S.A. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 17, 2026
- Legal name
- Orion S.A.
- CIK
- 0001609804
Orion S.A. Β· OEC
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $1.5B | $2.0B | $1.9B | $1.9B | $1.8B |
| Revenue growth | 36.1% | 31.3% | β6.7% | β0.9% | β3.8% |
| Gross margin | 25.0% | 22.1% | 23.8% | 22.8% | 19.9% |
| Operating margin | 14.8% | 9.7% | 10.8% | 5.5% | 1.5% |
| Net income | $135M | $106M | $104M | $44.2M | β$70.1M |
| Net margin | 8.7% | 5.2% | 5.5% | 2.4% | β3.9% |
| Diluted EPS | $2.21 | $1.73 | $1.73 | $0.76 | β$1.24 |
| Cash | |||||
| Cash from operations | $145M | $81.0M | $346M | $125M | $216M |
| Capital expenditure | $215M | $233M | $173M | $207M | $161M |
| Free cash flow | β$69.5M | β$152M | $173M | β$81.4M | $54.8M |
| FCF margin | β4.5% | β7.5% | 9.1% | β4.3% | 3.0% |
| Dividends paid | $0.0M | $5.0M | $4.9M | $4.8M | $4.7M |
| Share buybacks | $0.0M | $4.3M | $65.6M | $26.6M | $24.8M |
| Share count change | β0.7% | 0.7% | β2.3% | β2.7% | β3.5% |
| Debt and strength | |||||
| Cash and short-term investments | $65.7M | $60.8M | $37.5M | $44.2M | $60.7M |
| Debt incl. finance leases | $997M | $1.3B | $1.0B | $1.2B | $1.4B |
| Shareholders' equity | $320M | $459M | $479M | $475M | $385M |
| Net debt / EBITDA | 2.8x | 3.9x | 3.2x | 5.3x | 8.1x |
| Current ratio | 1.5x | 1.4x | 1.5x | 1.2x | 1.0x |
| Interest coverage | 6.0x | 4.9x | 4.0x | β | β |
| Returns and quality | |||||
| Return on capital | 13.9% | 8.5% | 9.6% | 5.3% | 1.4% |
| Return on equity | 53.8% | 27.3% | 22.1% | 9.3% | β16.3% |
| Return on tangible equity | 65.6% | 29.6% | 27.5% | 11.5% | β18.9% |
| Piotroski F-score | 7 | 3 | 8 | 4 | 3 |
| Altman Z'' | 2.5 | 2.4 | 2.6 | 1.9 | 1.1 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Orion S.A. Β· OEC
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $5.37 a share, the company is worth $308M.
Source: SEC EDGAR XBRL filings (CIK 0001609804). Data updated October 24, 2026. For information only β not investment advice. Check the original filings before relying on any figure.
